 Home > Medical News > Latest Medical News > Watson Bio's bivalent HPV vaccine officially approved

Watson Bio's bivalent HPV vaccine officially approved

 Last Update: 2022-04-22
 Source: Internet
 Author: User

Tags

hr breast cancer

tnbc breast cancer

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On March 24, the State Food and Drug Administration showed that the recombinant human papillomavirus bivalent (type 16/18) vaccine (yeast) independently developed by Zerun Bio, a subsidiary of Watson Bio has been approved for marketing, becoming the second Approved domestic bivalent HPV vaccine

Human papillomavirus (HPV) is a DNA virus with more than 100 subtypes

Public information shows that among female malignant tumors, the incidence of cervical cancer is second only to breast cancer, and most cervical cancers are caused by HPV infection

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

jobs united states(236)

united states jobs(223)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

ups united states(221)

announcements today(81)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.